NAD+ Affiliate Programs: Telehealth, NMN & Publisher Access
Choose the correct NAD-related affiliate route and keep clinician-led services, NMN supplements and research products clearly separated.
Apply for Private Publisher AccessFor NAD+ telehealth, use NAD+ Telehealth Affiliate Programs and apply for private publisher review. For the separate consumer NMN supplement, review HealthBuy NAD+ Boost affiliate information. The older GLP1 Research Lab links in this article are not retained as verified current offer destinations.
Two Current Directory Routes With Different Purposes
NAD+ telehealth publisher inquiries
The public category page explains private publisher access. Advertiser identity, campaign availability, approved markets, payout events, creative and tracking are reviewed through the private process. It is not a patient intake page or a guarantee of a specific service format.
View NAD+ telehealth informationHealthBuy NAD+ Boost NMN supplement
This is a separate consumer product program. Use its current program page to review the official HealthBuy product and store links and the applicable affiliate signup routes. Do not describe this supplement as the same product or service as a clinical NAD+ program.
View the NMN supplement programWhat This Older Article No Longer Confirms
Earlier copy sent visitors to a GLP1 Research Lab NAD+ product and affiliate registration page. Those links are no longer used here to establish current availability or commercial terms. The fact that an older article named a supplier does not establish that the same campaign, product format or account terms still apply today.
Research-use materials, oral supplements and clinician-led services need separate evaluations. Do not transfer an intended use, a product image, an advertiser statement or an approval claim across those categories. NAD+ is not a peptide, even though its publisher page sits near longevity and peptide topics in the broader directory.
Match the Program to the Visitor's Intent
A publisher researching clinical-service partnerships should reach the telehealth application route. A reviewer covering a consumer supplement should inspect that exact product's current label and official store page. A research-business inquiry needs the intended audience and permissions for its own program; it should not be framed as a patient treatment offer.
Make that choice visible in article headings and calls to action. A page that says only “NAD+ offer” can blur very different products and services. Clear labels help visitors understand what they will find after clicking and help publishers avoid reusing irrelevant claims.
Confirm Terms Before Sending Traffic
- Identify the exact operator and product or service.
- Confirm the eligible geography, audience and approved landing page.
- Record the payable event, commission basis, attribution and reversals.
- Check current creative, allowed traffic channels and approved messaging.
- Use only the tracking link assigned to the approved campaign.
No fixed payout, service route, treatment benefit or lifespan claim is verified by this article. The current approved brief controls promotion.
Frequently Asked Questions
Where do I apply for NAD+ telehealth affiliate access?
Is HealthBuy NAD+ Boost the same as NAD+ telehealth?
Are the old research supplier links current offer confirmations?
Is NAD+ a peptide?
Commercial information reviewed October 15, 2026. This article retains its original URL. The current approved program brief controls availability, eligibility and permitted promotion.